N
CTSO icon

Nuveen’s Cytosorbents Corp CTSO Stock Holding History

Nuveen’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-135,134
Closed -$420K – 3296
2022
Q1 		$420K Buy
135,134
+1,137
+0.8% +$4.07K ﹤0.01% 3062
2021
Q4 		$594K Sell
133,997
-13,789
-9% -$77.4K ﹤0.01% 3027
2021
Q3 		$1.29M Sell
147,786
-4,279
-3% -$34.8K ﹤0.01% 2881
2021
Q2 		$1.15M Sell
152,065
-9,537
-6% -$80.4K ﹤0.01% 2957
2021
Q1 		$1.4M Buy
161,602
+921
+0.6% +$8.78K ﹤0.01% 2771
2020
Q4 		$1.28M Buy
160,681
+11,784
+8% +$98.6K ﹤0.01% 2714
2020
Q3 		$1.19M Buy
148,897
+7,607
+5% +$68.6K ﹤0.01% 2611
2020
Q2 		$1.4M Buy
141,290
+20,581
+17% +$189K ﹤0.01% 2479
2020
Q1 		$933K Buy
120,709
+10,311
+9% +$52.1K ﹤0.01% 2541
2019
Q4 		$425K Hold
110,398
– – ﹤0.01% 2943
2019
Q3 		$555K Sell
110,398
-6,149
-5% -$35.8K ﹤0.01% 2908
2019
Q2 		$770K Buy
+116,547
New +$801K ﹤0.01% 2848

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen's CTSO Position: Q2 2022 in Review

Nuveen sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 135,134 shares — an estimated $420K sold.

Nuveen first reported a position in CTSO in Q2 2019 and held it in 12 quarters. The position peaked at $1.4M in Q1 2021. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

  • Nuveen reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 135,134 Cytosorbents Corp shares in Q2 2022, an estimated $420K.
  • Nuveen first reported a position in Cytosorbents Corp in Q2 2019 and held it in 12 quarters.
  • Nuveen's Cytosorbents Corp position peaked at $1.4M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.